Background-Current
O utcomes of patients who present with ST-segmentelevation myocardial infarction (STEMI) are time dependent, with increasing time to reperfusion associated with worse outcomes. 1 Important additional factors associated with outcomes include patient characteristics, 2 physician volume, [3] [4] [5] and hospital procedural volume. [4] [5] [6] [7] [8] [9] [10] [11] Hospital procedural volume has been a consistent predictor of outcomes for multiple cardiac procedures, 11, 12 including primary percutaneous coronary intervention (PCI) for STEMI. [4] [5] [6] [7] [8] The point at which volume affects outcomes has varied among studies. Initial studies, performed before primary PCI was the preferred reperfusion method, demonstrated a significant reduction in mortality when yearly primary PCI hospital volume exceeded 13 6 or 33 7 patients/y. Most, 9, 11 but not all, 13 recent studies, in which coronary stenting and use of newer pharmacological treatments are routine, have continued to demonstrate improved outcomes with higher hospital volumes. Current guidelines for primary PCI recommend a minimum 36 primary PCIs per hospital per year. However, recent data supporting this volume recommendation are lacking. 14 In addition, the number of hospitals performing PCI has increased, 15 despite no significant change in the annual rate of PCI, 16 suggesting that the number of PCIs per hospital has decreased. Because procedural volume is increasingly being used as a surrogate for quality of care 10 by several organizations and agencies, additional examination of the volume relationship with outcomes is warranted.
We hypothesized that higher volume primary PCI hospitals would be associated with lower mortality and shorter doorto-balloon (D2B) times compared with low-volume hospitals.
Methods

Data Source
The CathPCI Registry is a large, ongoing registry of clinical data and procedural outcomes associated with diagnostic cardiac catheterization and PCI including >1400 participating sites sponsored by the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. 17 Data are captured by the National Cardiovascular Data Registry (NCDR)-certified databases at participating hospitals and include patient and hospital characteristics, procedural findings, interventions, and outcomes. The NCDR also has a data quality program, including data abstraction training, data quality thresholds for inclusion, site data quality feedback reports, independent auditing, and data validation. 18 Data auditing has demonstrated accurate representation with agreement with chart review of >93%. 19 Data elements and definitions are available at http://www.ncdr.com/ WebNCDR/ELEMENTS.ASPX#1.
Patient Population
We included all visits for patients presenting with STEMI from July 2006 to June 2009 using version 3 of the data-collection form. Visits were excluded if a patient did not undergo PCI during the visit or was not the first PCI during the hospital admission and if the PCI was not classified as emergent or salvage or was not primary PCI for STEMI ( Figure 1) . Patients who were transferred in for primary PCI were excluded, as this may represent selection bias and a higher risk group. 7 Patients in whom the D2B time was either unknown, <15 minutes, or >6 hours or received thrombolytics before PCI were excluded. In addition, hospitals were excluded if they treated >20% of their patients with thrombolytics because this may identify hospitals that are preferentially treating lower risk patients 20 or transferred out >10% of their patients because of inability to assess mortality. Finally, consistent with prior studies, we excluded visits in hospitals with an annual volume of <5 cases/y. 6, 7, 13 The final study sample included 87 324 admissions for 86 044 patients from 738 hospitals.
Main Interested Variable, Outcomes, and Subgroups
Hospital annual volume was calculated as: (number of admissions)/ (number of quarters the hospital contributed data to the registry in the 3 years) multiplied by 4. Hospitals were separated into 3 groups based on annualized primary PCI volume: low volume (n=278), hospitals performing ≤36 primary PCIs a year (current guidelines).
14 The remaining 460 (62%) hospitals were separated into 2 relatively equal groups: intermediate volume (n=236), 37 to 60 primary PCIs/y, and high volume (n=224), >60 primary PCIs/y.
The primary end points of this study were D2B time and in-hospital mortality. Secondary outcomes included complications (vascular complications, emergent bypass surgery, bleeding, and transfusion) during the admission.
Two specific subgroups were predefined based on the likelihood of worse outcomes: patients presenting during off hours (presentation from 5 PM to 7 AM Monday to Friday or on weekends) and patients presenting with cardiogenic shock at the time of admission (a sustained episode of hypotension, cardiac index <2.2 L/min per m 2 secondary to cardiac dysfunction, or the requirement for inotropic or vasopressor agents or mechanical support).
Statistical Analysis
We evaluated the baseline patient clinical characteristics, hospital characteristics, and outcomes among the hospital groups determined
WHAT IS KNOWN
• Hospital procedural volume has been a consistent predictor of outcomes for primary percutaneous coronary intervention (PCI) for ST-segment-elevation myocardial infarction, resulting in the current competency statements and guidelines that recommend >36 primary PCISs per hospital per year.
• Whether these standards remain valid when routine coronary stenting and newer pharmacological agents are used is unclear.
WHAT THE STUDY ADDS
• In a large cohort of consecutive patients who underwent primary PCI included in the CathPCI Registry, the majority (54%) were treated at high-volume hospital (>60 primary PCIs/y), with 15% at low-volume hospitals (<36 primary PCIs/y 21 with the addition of D2B time, but different modeling was used as different end points were evaluated. D2B time was analyzed using Cox regression, with censoring at 90 minutes, with similar variables included. Odds ratios for low-and intermediate-volume hospitals were reported using high-volume hospitals as the reference group.
The Human Investigation Committee of the Yale University School of Medicine approved the use of data from the NCDR Registry for research purposes. CathPCI Registry is an initiative of the American College of Cardiology Foundation and the Society for Cardiovascular Angiography and Interventions.
Results
Baseline Characteristics
A total of 87 324 admissions for 86 044 patients presenting to 738 hospitals were included in the analysis. There were 278 hospitals (38%) classified as low-volume, 236 (32%) as intermediate-volume, and 224 (30%) as high-volume hospitals. The majority of patients with primary PCI (54%) were treated at high-volume hospitals, with lesser percentages at intermediate-(30%) and low-volume hospitals (15%; Table 1 ). Low-volume hospitals performed fewer total PCIs and were less likely to have cardiac surgery backup. High-volume hospitals were more likely to be urban than rural or suburban and were more likely to be a private/community hospital than an academic hospital.
Distributions of age and sex were comparable and not significantly different across the 3 groups (Table 2 ). Absolute differences were relatively small among most of the other variables, although they were statistically different, including diabetes mellitus, renal function, prior myocardial infarction, and prior revascularization. Patients with heart failure on admission were more common at low-volume hospitals (10.6%) compared with intermediate-volume (9.2%) and high-volume (8.5%) hospitals (P<0.0001; Table 2 ). A total of CABG indicates coronary artery bypass surgery; CHF, congestive heart failure; GFR, glomerular filtration rate; MI, myocardial infarction; and PCI, percutaneous coronary intervention.
Angiographic Results
The infarct-related artery was most commonly the right coronary artery (48%) followed by the left anterior descending artery (40%; Unadjusted in-hospital mortality was significantly lower in high-volume hospitals compared with low-volume hospitals (4.8% versus 5.6%; P<0.0001; Figure 3 ; Table 5 ). However, mortality between intermediate-and high-volume hospitals (4.8% versus 4.8%) was similar. The correlation with hospital volume and mortality (r 2 =0.02; Figure 4A ) and D2B times (r 2 =0.04; Figure 4B ) was very low. Bleeding complications and need for blood products (all P<0.0001) were significantly higher in high-volume hospitals (Table 5) . D2B times were slower for patients presenting off hours versus overall by ≈6 minutes, a finding consistent across all volume groups. Off-hour D2B times remained significantly shorter in high-compared with low-volume hospitals ( 
Multivariate Analysis
After multivariate adjustment for patient and hospital characteristics, mortality was significantly higher (1.22; 95% confidence interval, 1.10-1.35; P<0.0001) in low-volume compared with high-volume hospitals. After further adjustment for D2B time, mortality remained significantly higher in low-volume centers (1.20; 95% confidence interval, 1.08-1.33; Table 6 ). In contrast, mortality was not significantly different between intermediate-volume and highvolume hospitals (adjusted odds ratio, 1.02; 95% confidence interval, 0.94-1.11; P=0.61). A sensitivity analysis was performed in which transfer-in patients were included; mortality remained significantly different for low-volume versus highvolume centers (odds ratio, 1.14; 95% confidence interval, 1.005-1.26; P<0.04).
Results were similar in the subgroups of patients who presented off hours, in which mortality was significantly higher in low-volume hospitals, with no significant difference between intermediate-volume and high-volume hospitals (Table 6 ). However, there was no significant difference in mortality in patients with cardiogenic shock among the 3 groups. In the subgroup of patients without cardiogenic shock, mortality remained higher in low-volume centers (2.7%) compared with intermediate-volume and high-volume centers (2.2% for both; P<0.004), which was significant after multivariate analysis (1.24; 95% confidence interval, 1.08-1.43; P=0.003).
After multivariate adjustment, low-volume hospitals were significantly less likely to achieve a D2B time ≤90 minutes compared with high-volume hospitals for all groups (Table 7) . Intermediate-volume hospitals were less likely to achieve a D2B time ≤90 minutes, when considering all patients and those presenting off hours, but not those with cardiogenic shock (Table 7) .
Discussion
Our results indicate that higher hospital primary PCI volume is associated with lower in-hospital mortality. After adjusting for patient and procedural variables, the risk of mortality was increased by 20% in low-volume as compared with high-volume hospitals. In addition, D2B time was significantly shorter in high-volume hospitals.
PCI Volume and Outcomes
Current guidelines recommend that primary PCI for STEMI should be performed in institutions that perform >200 elective PCIs per year and >36 primary PCI procedures for STEMI per year.
14 When the initial recommendations were developed, it was recognized that threshold activity level standards for institutions and operators was controversial because of the limited available data. 22 Since the publication of the initial guidelines, the relationship between hospital volume and outcomes in patients undergoing PCI has been extensively investigated. Although the specific volume cut point and the method of assessing volume (provider, hospital) have varied, most studies have found that higher volumes are associated with lower mortality at the hospital 4,5,9-11 and operator [3] [4] [5] 23 levels. This relationship has persisted in more recent studies.
5,9,10
Primary PCI Studies
Data from clinical registries including patients undergoing primary PCI, such as the New York Coronary Angioplasty Reporting System Registry 4 and the National Registry of Myocardial Infarction (NRMI)-2, 6-8 have mirrored those of results of studies including a broad spectrum of patients undergoing PCI, with significantly lower mortality 7, 8 as well as shorter D2B times 7 in higher volume hospitals, defined as >33 8 or 36 7 primary PCIs per year. Despite demonstrating a volume/mortality relationship, several factors potentially limit the ability to extrapolate these studies to current practice. Most were performed before primary PCI became the preferred treatment for STEMI, many patients underwent treatment with fibrinolytics, even at high-volume primary PCI hospitals, and there was less emphasis on achieving rapid reperfusion.
6-8 As a result, D2B times were substantially longer than in current practice, with median times >40 minutes longer 7 than those currently routinely achieved. 24 In addition, contemporary practice and management have changed substantially, with increased use of evidence-based therapies, standardization of care, and reduced practice variation. 25 The routine use of stenting has further decreased the risk of complications and adverse outcomes. 14 Two recent studies have reported on the hospital volume/ outcome relationship in patients undergoing primary PCI. Srinivas et al 3 examined the relationship between volume and mortality using the New York PCI database in 7321 patients undergoing primary PCI and found that lower volume for physicians (<10 primary PCIs/y) and hospitals (<50 primary PCIs/y) was associated with a significantly increased in-hospital mortality.
In contrast, Kumbhani et al, 13 using data from the Get With the Guidelines Registry, found that mortality was higher in low-volume centers, and it was not significant. In this study, 29 513 patients underwent primary PCI at 166 hospitals. Low-volume primary PCI hospitals (defined as <36 primary PCIs/y) had significantly longer D2B times (98 versus 88 minutes; P<0.001) compared with high-volume hospitals (>70 primary PCIs/y). However, unadjusted (3.9% versus 3.0%; were not significantly different.
The relative and absolute differences in the mortality found in the 2 studies were similar; however, because smaller numbers of hospitals (166 versus 738) and patients (29 513 versus 87 324) who were at lower risk (overall in-hospital mortality 3.2 versus 4.9%) were included by Kumbhani et al 13 compared with the current study may have limited the ability to demonstrate a significant difference in outcomes.
D2B Times
We found that D2B times were significantly longer in lowvolume as compared with intermediate-volume and highvolume hospitals. However, this difference, a median of 3 to 4 minutes, with an additional 5% to 6% of patients with a D2B >90 minutes, is unlikely to explain the mortality difference with high-volume hospitals. 26 Rather, shorter D2B times likely reflect improved processes of care at these hospitals. In addition, the low correlation that D2B times and mortality had with hospital volume indicates that other factors contribute to the reduced mortality that cannot be easily measured. These may include hospital processes of care, infrastructure for quality improvement, and interdepartmental and interdisciplinary co-ordination and communication.
Study Implications
Our data, which include ≈85% of cardiac catheterization laboratories performing PCI in the United States, 17 and therefore are representative of current clinical practices, indicate that hospital primary PCI volume continues to be an important predictor of in-hospital STEMI mortality. It is possible that activity below a specific threshold would limit the ability of catheterization laboratory and intensive care staff to gain the experience and expertise required to rapidly and effectively treat complicated and high-risk patients with STEMI undergoing primary PCI, particularly in emergent situations. 27 This may explain the lower mortality in higher volume centers, despite increased complications, such as bleeding, that have been associated with higher mortality.
The relationship between volume and outcomes seems to be continuous. Our data indicate that current guidelinerecommended volume numbers seem reasonable, 14 as hospitals with <36 primary PCIs/y had significantly higher mortality than those with ≥36/y. The lack of a mortality difference between centers with a primary PCI volume of 30 to 60/y and those >60/y suggests that selection of a higher volume requirement may not lead to significant differences in mortality.
Despite a significant increase in hospitals capable of performing PCI (from 1176 in 2001 to 1695 in 2006; relative 44% increase), the proportion of Americans estimated to live within 60 minutes of a PCI center has not changed. 15, 28 The PCI utilization rate has remained stable and not significantly changed since 2001, 16 consistent with most of the newer PCI hospitals being near ones that already exist, rather than in areas of need, further reducing hospital procedure volumes.
29,30
Limitations
The volume criteria we chose, although different from prior studies, were chosen to reflect current guideline recommendations. We did not analyze data using provider volume so we were unable to assess the role of provider experience on outcomes. We did not include symptom onset-to-balloon time and total hospital PCI volume in the mortality model. We were limited to in-hospital mortality; it is possible that differences we found would have increased over time, particularly in patients with cardiogenic shock. 31, 32 We excluded transferin patients, as these patients may represent selection bias and a higher risk group. 7 However, inclusion did not change the overall results. An unequal geographic distribution of participating hospitals could lead to selection bias, which limits the proportion of the STEMI population that was evaluated during the study period. We included only hospitals participating in Cath/PCI; however, this registry includes ≈85% of cardiac catheterization laboratories performing PCI in the United States 17 and therefore is likely representative of current clinical practices. Because data used for our study are self-reported, there is a potential for data errors. However, before inclusion in the registry, data are filtered through the registry-specific algorithms that require predetermined levels of completeness and consistency for submitted data fields as part of the data quality report. A recent report indicated a high degree of agreement.
17
Conclusions
Despite improvements in D2B times and reductions in overall mortality, our data show that hospitals with a primary PCI volume that <36 primary PCIs per year has a significantly higher mortality than hospitals with higher primary PCI volume.
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